Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675527 · ClinicalTrials.gov registry record · Phase 4
PRP for Glenohumeral Osteoarthritis
A Phase 4 study of Shoulder Osteoarthritis, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT05675527 is a Phase 4 study of Shoulder Osteoarthritis that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 135 participants, below the 190-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05675527, a Phase 4 study of Shoulder Osteoarthritis, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
The glenohumeral joint is the third most common large joint to be affected by OA. Conservative treatments include physical activity, corticosteroid injections, and medications. PRP is an emerging treatment that has shown efficacy in different musculoskeletal conditions. The use of PRP for glenohumeral OA has been described sparingly in the literature but has shown efficacy in a couple studies and case reports. However, all of the previous studies investigating PRP for glenohumeral OA have focused on low-dose PRP preparations (\~3X), and none have compared PRP treatment to saline treatment. This study aims to compare outcomes following single injections of low-dose PRP, high-dose PRP, or saline in patients with glenohumeral osteoarthritis.
Conditions Studied
Interventions
- OTHER Saline
- BIOLOGICAL Low-dose PRP
- BIOLOGICAL High-dose PRP
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05675527
The ClinicalTrials.gov registry entry for NCT05675527 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (29% lower). The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Shoulder Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.
NCT05675527 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05675527 about?
NCT05675527 is a clinical study titled "PRP for Glenohumeral Osteoarthritis". The glenohumeral joint is the third most common large joint to be affected by OA. Conservative treatments include physical activity, corticosteroid injections, and medications. PRP is an emerging treatment that has shown efficacy in different musculoskeletal conditions. The use of PRP for glenohumer...
What is the current status of trial NCT05675527?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 135 participants. The study started on 2023-05-02. Estimated completion is 2026-09-01.
What conditions does trial NCT05675527 study?
This clinical trial studies the following conditions: Shoulder Osteoarthritis.
What interventions are being tested in trial NCT05675527?
The interventions under investigation include: Saline (OTHER), Low-dose PRP (BIOLOGICAL), High-dose PRP (BIOLOGICAL).
Who is sponsoring clinical trial NCT05675527?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675527 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
RECRUITING · Phase 4
-
Opioid-Free Shoulder Arthroplasty
COMPLETED · Phase 4
-
Rehabilitation Following Reverse Total Shoulder Arthroplasty
RECRUITING · NA
-
AETOS Shoulder System
RECRUITING
-
CBD for Pain Following Orthopedic Shoulder Surgery
RECRUITING · Phase 1
-
Return to Golf After Orthopaedic Surgery
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.